Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. australasia
  4. cancer risk mouse study
Show results for
Products
Services

Companies


Refine by
Locations
Back to All Locations

  • Australasia
  • American Samoa
  • Australia
  • Fiji
  • Kiribati
  • Marshall Islands
  • Micronesia
  • New Zealand
  • Palau
  • Papua New Guinea
  • Solomon Islands
  • Tonga
  • Tuvalu
  • Vanuatu
Brands

  • cartherics
  • colostat
  • cxcolorectal
  • inoviq

Cancer Risk Mouse Study Equipment Supplied In Australasia

4 equipment items found
In AustralasiaAvailable In AustralasiaNear Australasia

Cartherics - Model CTH-401 - Allogeneic Products

Cartherics - Model CTH-401 - Allogeneic Products

Manufactured by:Cartherics Pty ltd   based inNotting Hill, AUSTRALIA
Indication: Ovarian Cancer. Research: iNK cells [TAG-72 CAR + gene ...
CONTACT SUPPLIER

Cxcolorectal - Urine Sampling System

Cxcolorectal - Urine Sampling System

Manufactured by:Pacific Edge Ltd   based inDunedin,, NEW ZEALAND
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment for the ...
CONTACT SUPPLIER

ColoSTAT - Blood Test Tool

ColoSTAT - Blood Test Tool

Manufactured by:Rhythm Biosciences Limited   based inParkville, AUSTRALIA
The ColoSTAT technology has the potential to become the new, first step screening test for people, who for personal, cultural or clinical reasons, elect to not participate in the existing screening programs for colorectal ...
CONTACT SUPPLIER

Inoviq - Model SubB2M - Pan-Cancer Probe

Inoviq - Model SubB2M - Pan-Cancer Probe

Manufactured by:INOVIQ Ltd   based inNotting Hill, AUSTRALIA
INOVIQ has the exclusive worldwide license for SubB2M - an engineered protein that binds to a unique sugar molecule called Neu5Gc which is only present in human cancers. In initial clinical studies, SubB2M has detected cancers with 100% sensitivity and specificity for mid to late-stage cancers, and >95% specificity and 100% sensitivity for early-stage cancers. There is also evidence that ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT